Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Standard noninvasive methods for detecting renal allograft rejection and injury have poor sensitivity and specificity. Plasma donor-derived cell-free DNA (dd-cfDNA) has been reported to accurately detect allograft rejection and injury in transplant recipients and shown to discriminate rejection from stable organ function in kidney transplant recipients. This study used a novel single nucleotide polymorphism (SNP)-based massively multiplexed PCR (mmPCR) methodology to measure dd-cfDNA in various types of renal transplant recipients for the detection of allograft rejection/injury without prior knowledge of donor genotypes. A total of 300 plasma samples (217 biopsy-matched: 38 with active rejection (AR), 72 borderline rejection (BL), 82 with stable allografts (STA), and 25 with other injury (OI)) were collected from 193 unique renal transplant patients; dd- cfDNA was processed by mmPCR targeting 13,392 SNPs. Median dd-cfDNA was significantly higher in samples with biopsy-proven AR (2.3%) versus BL (0.6%), OI (0.7%), and STA (0.4%) (p < 0.0001 all comparisons). The SNP-based dd-cfDNA assay discriminated active from non-rejection status with an area under the curve (AUC) of 0.87, 88.7% sensitivity (95% CI, 77.7–99.8%) and 72.6% specificity (95% CI, 65.4–79.8%) at a prespecified cutoff (>1% dd-cfDNA). Of 13 patients with AR findings at a routine protocol biopsy six-months post transplantation, 12 (92%) were detected positive by dd-cfDNA. This SNP-based dd-cfDNA assay detected allograft rejection with superior performance compared with the current standard of care. These data support the feasibility of using this assay to detect disease prior to renal failure and optimize patient management in the case of allograft injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526 · cited 1×
“Because the distribution of dd-cfDNA in patients was severely skewed among the groups, data were analyzed using a Kruskal–Wallis rank sum test followed by Dunn multiple comparison tests with Holm correction [23,24].”
MethodLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923 · cited 2×
“I ter- and intr -variability in dd-cfDNA over time was evaluated using a mixed effects model with a loga ithmic transformation on dd-cfDNA [29]; 95% confid nce intervals (CI) for the intra- and inter-patient standard deviations were calculated using a likelih od profile method.”
MethodEfron, B., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013815 · Cited by 6,033 · cited 1×
“To calculate the performance parameters of each marker (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC)), a bootstrap method was used to account for repeated measurements within a patient [28].”
MethodMultiple Comparisons Using Rank Sums
Dunn, O. J. (1964) · Technometrics · doi:10.1080/00401706.1964.10490181 · Cited by 5,085 · cited 1×
“Because the distribution of dd-cfDNA in patients was severely skewed among the groups, data were analyzed using a Kruskal–Wallis rank sum test followed by Dunn multiple comparison tests with Holm correction [23,24].”
MethodSmall sample inference for fixed effects from restricted maximum likelihood
Kenward, M. G., & Roger, J. H. (1997) · Biometrics · doi:10.2307/2533558 · Cited by 4,552 · cited 1×
“It is possible that the overall effect is driven by a sub-category of the non-rejection group (STA, BL, or OI) or the effect between the groups is smaller than detectable with the current sample size [30].”
BackgroundNew Equations to Estimate GFR in Children with CKD
Schwartz, G. J., Mun[Combining Tilde]oz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030287 · Cited by 3,777 · cited 1×
“eGFR (serum creatinine in mg/dL) was calculated as described previously for adult [25] and pediatric patients [26].”
MethodPhylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Self-citationHaas, M., Loupy, A., Lefaucheur, C., Roufosse, C., Glotz, D., Seron, D., Nankivell, B. J., Halloran, P. F., Colvin, R. B., Akalin, E., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14625 · Cited by 1,041 · cited 2×
“All pathology samples were read at UCSF by a single renal pathologist and rated according to the recently updated Banff criteria [18].”
MethodLoupy, A., Haas, M., Solez, K., Racusen, L., Glotz, D., Seron, D., Nankivell, B. J., Colvin, R. B., Afrouzian, M., Akalin, E., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14107 · Cited by 629 · cited 1×
“There is a current unmet need for a rapid, accurate, and noninvasive approach to detecting allograft rejection and/or injury—one which may require integration of the current “gold” standard morphological assessments with modern molecular diagnostic tools [8].”
BackgroundRejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605 · cited 1×
“Though advances in immunosuppressive drugs, organ procurement methods, and human leukocyte antigen-typing have lowered the number of clinical- and biopsy-confirmed rejection episodes, sub-clinical rejection of kidney grafts remains a significant risk [2,3].”
BackgroundCell-Free DNA and Active Rejection in Kidney Allografts
Bloom, R. D., Bromberg, J. S., Poggio, E. D., Bunnapradist, S., Langone, A. J., Sood, P., Matas, A. J., Mehta, S., Mannon, R. B., Sharfuddin, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016091034 · Cited by 584 · cited 7×
“These results are novel considering that a previously conducted study by Bloom et al. (2017), which used a different assay, found significantly higher dd-cfDNA levels for ABMR (2.9”
BackgroundMethodResultInfluentialCirculating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection
De Vlaminck, I., Valantine, H. A., Snyder, T. M., Strehl, C., Cohen, G., Luikart, H., Neff, N. F., Okamoto, J., Bernstein, D., Weisshaar, D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007803 · Cited by 549
Universal noninvasive detection of solid organ transplant rejection
Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013924108 · Cited by 385
Crespo, M., Pascual, M., Tolkoff-Rubin, N., Mauiyyedi, S., Bernard Collins, A., Fitzpatrick, D., Lin Farrell, M., Williams, W. W., Delmonico, F. L., Benedict Cosimi, A., et al. (2001) · Transplantation · doi:10.1097/00007890-200103150-00013 · Cited by 351 · cited 1×
“All kidney biopsies were analyzed in a blinded manner by a UCSF pathologist and were graded by the 2017 Banff classification [18] for active rejection (AR); intragraft C4d stains were performed [19] to assess for acute humoral rejection [20].”
MethodZimmermann, B., Hill, M., Gemelos, G., Demko, Z., Banjevic, M., Baner, J., Ryan, A., Sigurjonsson, S., Chopra, N., Dodd, M., et al. (2012) · Prenatal Diagnosis · doi:10.1002/pd.3993 · Cited by 328 · cited 1×
“Target enrichment was accomplished using massively multiplexed-PCR (mmPCR) using a modified version of a previously described method [22], with 13,392 single nucleotide polymorphisms (SNPs) targeted.”
MethodSelf-citationPergament, E., Cuckle, H., Zimmermann, B., Banjevic, M., Sigurjonsson, S., Ryan, A., Hall, M. P., Dodd, M., Lacroute, P., Stosic, M., et al. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000363 · Cited by 284
Self-citationDar, P., Curnow, K. J., Gross, S. J., Hall, M. P., Stosic, M., Demko, Z., Zimmermann, B., Hill, M., Sigurjonsson, S., Ryan, A., et al. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.006 · Cited by 277
Self-citationBeck, J., Bierau, S., Balzer, S., Andag, R., Kanzow, P., Schmitz, J., Gaedcke, J., Moerer, O., Slotta, J. E., Walson, P., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210328 · Cited by 271
Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review
Knight, S. R., Thorne, A., & Lo Faro, M. L. (2019) · Transplantation · doi:10.1097/tp.0000000000002482 · Cited by 204
Biomarkers for kidney transplant rejection
Lo, D. J., Kaplan, B. E., & Kirk, A. D. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.281 · Cited by 144 · cited 1×
“Kidney transplant management is particularly challenging owing to the lack of sensitivity and specificity of the serum creatinine assay, which, in addition to the late detection of transplant injuries, makes immunosuppression dosage and adjustment far from personalized [4,5].”
BackgroundTransplant genetics and genomics
Yang, J., & Sarwal, M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.12 · Cited by 81 · cited 1×
“Furthermore, biopsy results are often plagued by expert reader variance and can lead to delayed diagnosis of active rejection, after which irreversible organ damage may have occurred [6,7].”
BackgroundSelf-citationRyan, A., Hunkapiller, N. M., Banjevic, M., Vankayalapati, N., Fong, N. L., Jinnett, K. N., Demko, Z., Zimmermann, B. G., Sigurjonsson, S., Gross, S. J., et al. (2016) · Fetal Diagnosis and Therapy · doi:10.1159/000442931 · Cited by 72
Self-citationAdvances in diagnostics for transplant rejection
Nasr, M., Sigdel, T. K., & Sarwal, M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1239530 · Cited by 53 · cited 1×
“Furthermore, biopsy results are often plagued by expert reader variance and can lead to delayed diagnosis of active rejection, after which irreversible organ damage may have occurred [6,7].”
BackgroundSelf-citationThe proteogenomic path towards biomarker discovery
Sigdel, T. K., & Sarwal, M. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2008.01018.x · Cited by 49 · cited 1×
“Kidney transplant management is particularly challenging owing to the lack of sensitivity and specificity of the serum creatinine assay, which, in addition to the late detection of transplant injuries, makes immunosuppression dosage and adjustment far from personalized [4,5].”
BackgroundSelf-citation
Cited by
Long-Term Survival after Kidney Transplantation
Hariharan, S., Israni, A. K., & Danovitch, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2014530 · Cited by 664
Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients
Levitsky, J., Kandpal, M., Guo, K., Kleiboeker, S., Sinha, R., & Abecassis, M. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16835 · Cited by 102
Metadata
- Authors
- Sigdel, T., Archila, F., Constantin, T., Prins, S., Liberto, J., Damm, I., Towfighi, P., Navarro, S., Kirkizlar, E., Demko, Z., Ryan, A., Sigurjonsson, S., Sarwal, R., Hseish, S.-C., Chan-On, C., Zimmermann, B., Billings, P., Moshkevich, S., & Sarwal, M.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-12-23
- Volume
- 8
- Issue
- 1
- Pages
- 19
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2905905397
- Cited by
- 219
- References
- 25
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.